BRIEF-Travere Therapeutics Q1 EPS USD -0.47 Vs. IBES Estimate USD -0.54

Reuters
Yesterday
BRIEF-Travere <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Q1 EPS USD -0.47 Vs. IBES Estimate USD -0.54

May 01 (Reuters) - Travere Therapeutics Q1 product sales USD 75.861 million vs. IBES estimate USD 77.6 million.

  • Q1 operating expenses USD 124.406 million
  • Q1 operating income USD -42.674 million vs. IBES estimate USD -47.2 million
  • Q1 net income USD -41.226 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10